{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:26Z","timestamp":1786997966994,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["106-S3395"],"award-info":[{"award-number":["106-S3395"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST105-2314-B-002-178-MY3"],"award-info":[{"award-number":["MOST105-2314-B-002-178-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.virusres.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:17:14Z","timestamp":1497399434000},"page":"304-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA"],"prefix":"10.1016","volume":"244","author":[{"given":"Hung-Chih","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.virusres.2017.06.010_bib0005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2017.06.010_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","article-title":"CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation","volume":"45","author":"Bhaya","year":"2011","journal-title":"Annu. Rev. Genet."},{"issue":"5","key":"10.1016\/j.virusres.2017.06.010_bib0015","doi-asserted-by":"crossref","first-page":"e1004090","DOI":"10.1371\/journal.ppat.1004090","article-title":"High-efficiency targeted editing of large viral genomes by RNA-guided nucleases","volume":"10","author":"Bi","year":"2014","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.virusres.2017.06.010_bib0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2013.170","article-title":"Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases","volume":"21","author":"Bloom","year":"2013","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.virusres.2017.06.010_bib0025","first-page":"301","article-title":"An efficient antiviral strategy for targeting hepatitis B virus genome using Transcription Activator-Like Effector Nucleases","volume":"22","author":"Chen","year":"2013","journal-title":"Mol. Ther."},{"issue":"6189","key":"10.1016\/j.virusres.2017.06.010_bib0030","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.1254082","article-title":"Virology Comment on Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"344","author":"Chisari","year":"2014","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.virusres.2017.06.010_bib0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.virusres.2017.06.010_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.virusres.2017.06.010_bib0045","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2010.20","article-title":"Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs","volume":"18","author":"Cradick","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2017.06.010_bib0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2017.06.010_bib0055","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.virusres.2017.06.010_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"issue":"31","key":"10.1016\/j.virusres.2017.06.010_bib0070","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virusres.2017.06.010_bib0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/cr.2017.16","article-title":"A non-viral CRISPR\/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo","volume":"27","author":"Jiang","year":"2017","journal-title":"Cell Res."},{"issue":"6096","key":"10.1016\/j.virusres.2017.06.010_bib0080","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.virusres.2017.06.010_bib0085","doi-asserted-by":"crossref","first-page":"22555","DOI":"10.1038\/srep22555","article-title":"Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing","volume":"6","author":"Kaminski","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2017.06.010_bib0090","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2017.06.010_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"Kennedy","year":"2015","journal-title":"Virology"},{"issue":"7587","key":"10.1016\/j.virusres.2017.06.010_bib0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.virusres.2017.06.010_bib0105","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1128\/JVI.75.11.5084-5089.2001","article-title":"Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus","volume":"75","author":"Kock","year":"2001","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.7150\/ijbs.16064","article-title":"An effective molecular target site in hepatitis B virus S gene for cas9 cleavage and mutational inactivation","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.virusres.2017.06.010_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcimb.2017.00091","article-title":"Removal of integrated hepatitis B virus DNA using CRISPR-Cas9","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9663","key":"10.1016\/j.virusres.2017.06.010_bib0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2017.06.010_bib0125","doi-asserted-by":"crossref","first-page":"pe186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates In vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"Suppl 1","key":"10.1016\/j.virusres.2017.06.010_bib0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13003","article-title":"Hepatitis B virus: new therapeutic perspectives","volume":"36","author":"Lin","year":"2016","journal-title":"Liver Int."},{"issue":"8","key":"10.1016\/j.virusres.2017.06.010_bib0135","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"6176","key":"10.1016\/j.virusres.2017.06.010_bib0140","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.virusres.2017.06.010_bib0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0150","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/AAC.01318-07","article-title":"Rolling circle amplification: a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA","volume":"52","author":"Margeridon","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.virusres.2017.06.010_bib0155","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"issue":"1-2","key":"10.1016\/j.virusres.2017.06.010_bib0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res."},{"issue":"12","key":"10.1016\/j.virusres.2017.06.010_bib0165","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virusres.2017.06.010_bib0175","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.virusres.2017.06.010_bib0180","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"issue":"7546","key":"10.1016\/j.virusres.2017.06.010_bib0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.virusres.2017.06.010_bib0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"41","key":"10.1016\/j.virusres.2017.06.010_bib0195","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3748\/wjg.v19.i41.6995","article-title":"Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach","volume":"19","author":"Rodriguez-Frias","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.virusres.2017.06.010_bib0200","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/gtc.12437","article-title":"Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus","volume":"21","author":"Sakuma","year":"2016","journal-title":"Genes Cells"},{"issue":"10003","key":"10.1016\/j.virusres.2017.06.010_bib0205","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2017.06.010_bib0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2017.06.010_bib0215","doi-asserted-by":"crossref","first-page":"pe216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"10.1016\/j.virusres.2017.06.010_bib0220","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/mt.2016.94","article-title":"Complete spectrum of CRISPR\/Cas9-induced mutations on HBV cccDNA","volume":"24","author":"Seeger","year":"2016","journal-title":"Mol. Ther."},{"issue":"6268","key":"10.1016\/j.virusres.2017.06.010_bib0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.virusres.2017.06.010_bib0230","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.virusres.2017.06.010_bib0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virusres.2017.06.010_bib0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.2908","article-title":"Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing","volume":"32","author":"Tsai","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.virusres.2017.06.010_bib0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.virusres.2017.06.010_bib0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00535-012-0668-y","article-title":"Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog","volume":"48","author":"Tseng","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.virusres.2017.06.010_bib0255","doi-asserted-by":"crossref","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-Mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog."},{"issue":"32","key":"10.1016\/j.virusres.2017.06.010_bib0260","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.3748\/wjg.v21.i32.9554","article-title":"Dual gRNAs guided CRISPR\/Cas9 system inhibits hepatitis B virus replication","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.virusres.2017.06.010_bib0265","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"issue":"7385","key":"10.1016\/j.virusres.2017.06.010_bib0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature10886","article-title":"RNA-guided genetic silencing systems in bacteria and archaea","volume":"482","author":"Wiedenheft","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2017.06.010_bib0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.genet.40.110405.090451","article-title":"DNA double-strand break repair: all's well that ends well","volume":"40","author":"Wyman","year":"2006","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.virusres.2017.06.010_bib0280","doi-asserted-by":"crossref","first-page":"pe00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0285","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/emi.2014.64","article-title":"Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance","volume":"3","author":"Yang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"issue":"9","key":"10.1016\/j.virusres.2017.06.010_bib0290","article-title":"Revisiting the natural history of chronic HBV infection","volume":"15","author":"Yang","year":"2016","journal-title":"Curr. Hepatol. Rep."},{"issue":"8","key":"10.1016\/j.virusres.2017.06.010_bib0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"10.1016\/j.virusres.2017.06.010_bib0300","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.virusres.2017.06.010_bib0305","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2017.06.010_bib0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virusres.2016.04.003","article-title":"CRISPR\/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse","volume":"217","author":"Zhu","year":"2016","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.virusres.2017.06.010_bib0315","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim","year":"2005","journal-title":"J. Hepatol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217302794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170217302794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:32:49Z","timestamp":1537849969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170217302794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":63,"alternative-id":["S0168170217302794"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2017.06.010","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}